Indivior Share Price | |
---|---|
Price | 1,422.00 |
Bid | 1,422.00 |
Ask | 1,436.00 |
Change | -13.00 (-0.91%) |
Volume | 300,126 |
Open | 1,450.00 |
High | 1,453.00 |
Low | 1,422.00 |
Prev. Close | 1,435.00 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 135.34m |
Market Capitalisation | £1.92b |
Market Size | 500 |
52 Week High | 1,927.00 |
52 Week High Date | 27-Jul-2023 |
52 Week Low | 1,128.00 |
52 Week Low Date | 19-Dec-2023 |
# Trades | 906 |
---|---|
Vol. Sold | 179,607 |
Sold Value | £2.56m |
Vol. Bought | 111,367 |
Bought Value | £1.60m |
PE Ratio | 1,810.48246 |
Earnings | 0.785426 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
07-May-24 | 16:37:45 | 1,422.00 | 500 | Sell* | 1,422.00 | 1,436.00 | 7,110 | A Automatic Execution |
07-May-24 | 16:37:09 | 1,422.00 | 2,417 | Buy* | 1,422.00 | 1,436.00 | 34.37k | A Automatic Execution |
07-May-24 | 16:37:09 | 1,422.00 | 83 | Sell* | 1,422.00 | 1,436.00 | 1,180 | A Automatic Execution |
07-May-24 | 16:37:02 | 1,422.00 | 417 | Sell* | 1,422.00 | 1,436.00 | 5,930 | A Automatic Execution |
07-May-24 | 16:37:02 | 1,422.00 | 400 | Sell* | 1,422.00 | 1,436.00 | 5,688 | A Automatic Execution |
07-May-24 | 16:37:02 | 1,422.00 | 1,683 | Sell* | 1,422.00 | 1,436.00 | 23.93k | A Automatic Execution |
07-May-24 | 16:35:16 | 1,422.00 | 127,207 | Sell* | 1,422.00 | 1,436.00 | 2m | UT Uncrossing Trade |
07-May-24 | 16:29:52 | 1,433.00 | 1 | Buy* | 1,478.00 | 1,379.00 | 14.33 | O Ordinary Trade was executed as an SI |
07-May-24 | 16:29:58 | 1,436.00 | 120 | Buy* | 1,431.00 | 1,436.00 | 1,723 | A Automatic Execution |
07-May-24 | 16:29:58 | 1,436.00 | 65 | Buy* | 1,431.00 | 1,436.00 | 933.40 | A Automatic Execution |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
18-Mar-24 | 15-Mar-24 | Transfer From | Ryan Preblick held the position of CFO & Executive Director at the time of this trade.Ryan Preblick | 0.00 | 3,920 | 229,089 | |
18-Mar-24 | 18-Mar-24 | Sell | Mark Crossley held the position of CEO at the time of this trade.Mark Crossley | 1,617.00 | GBX | 10,549 | 335,935 |
18-Mar-24 | 15-Mar-24 | Sell | Mark Crossley held the position of CEO at the time of this trade.Mark Crossley | 1,644.00 | GBX | 15,444 | 335,935 |
18-Mar-24 | 14-Mar-24 | Sell | Mark Crossley held the position of CEO at the time of this trade.Mark Crossley | 1,630.00 | GBX | 91,204 | 335,935 |
18-Mar-24 | 15-Mar-24 | Exercise of Option | Mark Crossley held the position of CEO at the time of this trade.Mark Crossley | 555.00 | GBX | 15,444 | 335,935 |
Indivior is working to change patients lives by developing medicines to treat addiction and serious mental illnesses.